From: Pipelle for Pregnancy (PIP): study protocols for three randomised controlled trials
 | Pre-study | Day 1-12 of cycle 1 | Day after procedure day | End of study/end of cycle 3 | About 6 weeks gestation | ≥12 weeks gestation | Birth |
---|---|---|---|---|---|---|---|
Eligibility screen | x | Â | Â | Â | Â | Â | Â |
Informed consent | x | Â | Â | Â | Â | Â | Â |
Randomisation | Â | x | Â | Â | Â | Â | Â |
Study intervention | Â | x | Â | Â | Â | Â | Â |
Pain (VAS) | Â | x | Â | Â | Â | Â | Â |
Adverse events | Â | x | x | Â | Â | Â | Â |
Bleeding | Â | Â | x | Â | Â | Â | Â |
Cycle characteristics (e.g., intercourse frequency, ovulation medication dose (PIP-PCOS only), via study diary) | Â | Â | Â | x | Â | Â | Â |
Clinical pregnancy | Â | Â | Â | Â | x | Â | Â |
Ongoing pregnancy | Â | Â | Â | Â | Â | x | Â |
Live birth | Â | Â | Â | Â | Â | Â | x |